Skip to main content
Log in

Genetic basis of the neurovirulence of type 1 polioviruses isolated from vaccine-associated paralytic patients

  • Original Papers
  • Published:
Archives of Virology Aims and scope Submit manuscript

Summary

We examined four type 1 polioviruses isolated from the stools of patients with vaccine-associated paralytic poliomyelitis in China. All of these isolates were shown to be Sabin derived viruses by restriction fragment length polymorphism assay after polymerase chain reaction and by sequencing of the viral genome encoding the viral coat protein, VP1. However, the same analysis of the 3D coding region suggested that two of the four isolates had the sequence of wild type poliovirus in the tested region. Furthermore there were also point mutations in the 5′ non-coding region. One was a single base change from U to C at nucleotide position 525, and the other three were from G to A at position 480. All the four strains were more neurovirulent than Sabin type 1 virus in transgenic mice with human poliovirus receptor gene. The data showed that the nucleotide positions of type 1 poliovirus which were identified to be in favor of the high neurovirulence were indeed changed during natural transmission, and suggested that the point mutation alone or a recombination of the vaccine type with wild type genome results in an acquisition of neurovirulence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Balanant J, Guillot S, Candrea A, Depeyroux F, Crainic R (1991) The natural genomic variability of poliovirus analyzed by a restriction fragment length polymorphism assay. Virology 184: 645–654

    Google Scholar 

  2. Christodoulou C, Colbere-Garapin F, Macadam A, Taffs LF, Marsden S, Minor PD, Horaud F (1990) Mapping of mutations associated with neurovirulence in monkeys infected with Sabin 1 poliovirus revertants selected at high temperature. J Virol 64: 4922–4929

    Google Scholar 

  3. Chumakov KM, Powers LB, Noonan KE, Roninson IB, Levenbook IS (1991) Correlation between amount of virus with altered nucleotide sequence and the monkey test for acceptability of oral poliovirus vaccine. Proc Natl Acad Sci USA 88: 199–203

    Google Scholar 

  4. Furione M, Guillot S, Otelea D, Balanant J, Candrea A, Crainic R (1993) Polioviruses with natural recombinant genomes isolated from vaccine-associated paralytic poliomyelitis. Virology 196: 199–208

    Google Scholar 

  5. Guillot S, Otelea D, Delpeyroux F, Crainic R (1994) Point mutations involved in the attenuation/neurovirulence alternation in type 1 and type 2 oral polio vaccine strains detected by site-specific polymerase chain reaction. Vaccine 12: 503–507

    Google Scholar 

  6. Hioki K, Kato H, Endo S, Saitoh M, Nomura T (1993) Planned production of poliovirus-sensitive transgenic mice. Exp Anim 42: 300–303 [in Japanese]

    Google Scholar 

  7. Horie H, Koike S, Kurata T, Sato Y, Ise I, Ota Y, Abe S, Hioki K, Kato H, Taya C, Nomura T, Hashizume S, Yonekawa H, Nomoto A (1994) Transgenic mice carrying the human poliovirus receptor: new animal model for study of poliovirus neurovirulence. J Virol 68: 681–688

    Google Scholar 

  8. Jie Li, Yoneyama T, Yoshida H, Yoshii K, Shimizu H, Miyamura T, Hou ZH, Zheng H, Fang Y, Zhang LB, Hagiwara A (1995) Genetic analysis of wild type 1 poliovirus isolated in China, 1985–1993. Res Virol 146: 415–422

    Google Scholar 

  9. Karber G (1931) Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche. Arch Exp Pathol Pharmakol 162: 480–483

    Google Scholar 

  10. Kawamura N, Kohara M, Abe S, Komatsu T, Tago K, Arita M, Nomoto A (1989) Determinants in the 5′ noncoding region of poliovirus Sabin 1 RNA that influence the attenuation phenotype. J Virol 63: 1302–1309

    Google Scholar 

  11. Koike S, Taya C, Kurata T, Abe S, Ise I, Yonekawa H, Nomoto A (1991) Transgenic mice susceptible to poliovirus. Proc Natl Acad Sci USA 88: 951–955

    Google Scholar 

  12. Lipskaya GY, Muzychenko AR, Kutitova OKSV, Equestre M, Drozdov SG, Bercoff RP, Agol VI (1991) Frequent isolation of intertypic poliovirus recombinants with serotype 2 specificity from vaccine-associated polio cases. J Med Virol 35: 290–296

    Google Scholar 

  13. Nkowane BM, Wassilak SGF, Orenstein WA, Bart KJ, Schonberger LB, Hinman AR, Kew OM (1987) Vaccine-associated paralytic poliomyelitis. United States: 1973 through 1984. J Am Med Assoc 257: 1335–1340

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Li, J., Zhang, L.B., Yoneyama, T. et al. Genetic basis of the neurovirulence of type 1 polioviruses isolated from vaccine-associated paralytic patients. Archives of Virology 141, 1047–1054 (1996). https://doi.org/10.1007/BF01718608

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01718608

Keywords

Navigation